Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
CANF Can-Fite BioPharma
- 1.7600
- 0.00000.00%
Close Feb 28 16:00 ET
- 1.8188
- +0.0588+3.34%
Post 20:01 ET
10.73MMarket Cap-0.68P/E (TTM)
1.8600High1.7275Low84.20KVolume1.8000Open1.7600Pre Close150.58KTurnover1.38%Turnover RatioLossP/E (Static)6.10MShares4.690052wk High4.32P/B10.73MFloat Cap1.290052wk Low--Dividend TTM6.10MShs Float1419.0000Historical High--Div YieldTTM7.53%Amplitude1.2900Historical Low1.7880Avg Price1Lot Size
Can-Fite BioPharma Key Stats
EPS
According to the latest financial report of Can-Fite BioPharma, the latest earnings per share (TTM) for the company is -1.52. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Can-Fite BioPharma's free cash flow? The latest report shows it as -2.81M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Can-Fite BioPharma shows that the company's current ratio is 2.93, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Can-Fite BioPharma, the quick ratio is 2.38, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Can-Fite BioPharma? The latest ROE figure is -28.79%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Can-Fite BioPharma, the total asset return on investment (ROA) is -17.25%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Can-Fite BioPharma's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Can-Fite BioPharma, the net profit margin is -1.07K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...